Ocean Biomedical, Inc.
OCEA · OTCMCIK 1869974fmd_07JZ4Z8A0N7E503ZVQ4A8EMCR6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jun 17, 2021 to Mar 31, 2025, 14 periods
| Line item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Net interest income | (1) | (2) | (2) |
| Research and development | 8 | 1 | 0 |
| Total operating expenses | 16 | 10 | 4 |
| Operating income | (16) | (10) | (4) |
| Interest expense | 0 | 0 | – |
| Other non-operating income (expense) | (1) | (104) | (6) |
| Net income | (17) | (114) | (9) |